Install any skill in seconds. Free to start, no credit card required.
Get Started Free →mims-harvard/tooluniverse-drug-repurposing
Identify drug repurposing candidates via target-based, compound-based, and disease-based strategies. Combines drug-target-disease network reasoning with mechanism rationale, clinical-trial precedent, and patent/regulatory feasibility.
Passed 12 of 17 test cases with the skill, and 6 of 17 without it.
and 5 more in the full report
8 fixed8 passed either way6 still failing0 broke
Tokens, turns and time describe resource use, not a dollar price.
One of 8 test cases the skill fixed. Same model, same prompt, with and without the skill.
To query FAERS report counts by drug name in ToolUniverse, which parameter key accepts the drug name argument?
| Checked | Without skill | With skill |
|---|---|---|
| Uses medicinalproduct as the parameter key for the drug name argument. | Missed | Passed |
The instructions your model reads when the skill loads.
Systematically identify and evaluate drug repurposing candidates using multiple computational strategies.
IMPORTANT: Always use English terms in tool calls. Respond in the user's language.
Start by asking: WHY might this drug work for a new disease? Three strategies:
Each strategy uses different tools and has different evidentiary weight. Identify which strategy applies FIRST, then choose the corresponding workflow below. Do not run all three strategies blindly — reason about which is most plausible given the drug's mechanism.
LOOK UP DON'T GUESS: Never assume a drug hits a target, never assume a target is disease-relevant, never assume pathway overlap. Verify each link with tool calls.
Phase 1: Disease & Target Analysis
Get disease info (OpenTargets), find associated targets, get target details
Phase 2: Drug Discovery
Search DrugBank, DGIdb, ChEMBL for drugs targeting disease-associated genes
Get drug details, indications, pharmacology
Phase 3: Safety & Feasibility Assessment
FDA warnings, FAERS adverse events, drug interactions, ADMET predictions
test cases passed, vs 6 / 17 without
More skills from the same source and nearby in the registry, with their headline benchmark lift.